J. Bentham et al., A DOUBLE-STAINING TECHNIQUE FOR DETECTION OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I BINDING TO RAT TIBIAL EPIPHYSEAL CHONDROCYTES, Journal of Endocrinology, 137(3), 1993, pp. 361
In the present study a double-staining technique was developed to inve
stigate simultaneous GH and insulin-like growth factor-I (IGF-I) bindi
ng to chondrocytes in a monolayer cell culture. Rat tibial epiphyseal
chondrocytes were isolated by enzymatic digestion and cultured in mono
layer. GH and IGF-I were labelled with biotin. The affinity of the bio
tin-labelled ligands was compared with unlabelled ligands in a radiore
ceptor assay. To study the distribution of GH and IGF-I binding in the
monolayer, chondrocytes were incubated with biotinylated ligands with
or without an excess of unlabelled ligands, followed by incubation wi
th Vectastain ABC complex, which was then reacted with diaminobenzidin
e (DAB). Double staining was accomplished by carrying out the first re
action with DAB in the presence of nickel ammonium sulphate to give a
black precipitate, followed by incubation with the second ligand, then
ABC complex and finally DAB in the absence of nickel ammonium sulphat
e to give a brown stain. The presence of type-II collagen was demonstr
ated by immunohistochemistry and used as a marker for differentiated c
hondrocytes. Biotin-labelled GH and biotin-labelled IGF-I exhibited do
se-dependent displacements of I-125-labelled GH and I-125-labelled IGF
-I respectively from the chondrocytes in a radioreceptor assay. The di
splacement curves were identical to those of unlabelled ligands indica
ting that the affinity was unaltered. Binding of biotinylated GH to ce
lls was seen throughout the culture in regions where there was little
or no type-II collagen staining. IGF-I binding was predominantly local
ized to cells at high density; areas which also showed a high degree o
f staining for type-II collagen. The different locations of binding su
ggest that epiphyseal chondrocytes in monolayer culture comprise a het
erogeneous cell population and that IGF-I and GH have different target
cells.